首页|补肾填髓方通过PI3K信号通路调节阿尔茨海默病模型中的突触损伤

补肾填髓方通过PI3K信号通路调节阿尔茨海默病模型中的突触损伤

扫码查看
目的 探讨补肾填髓方及其活性成分淫羊藿苷对阿尔茨海默病(AD)的治疗作用及其机制.方法 (1)动物实验.本研究使用无特定病原体(SPF)级别的雄性C57BL/6J野生型(WT)小鼠和APP/PS1 双转基因小鼠进行实验,将小鼠分为WT组(WT小鼠,n=5,每日给予蒸馏水)、APP/PS1 组(APP/PS1 双转基因小鼠,n=5,每日给予蒸馏水)和BSTSD组[APP/PS1 双转基因小鼠,n=5,以27 g/(kg·d)的剂量给予BSTSD悬浮液治疗 90 天].采用Morris水迷宫(MWM)评估认知功能.实验后收集海马组织,通过苏木精-伊红(HE)染色和透射电子显微镜(TEM)分析锥体细胞和突触形态.(2)细胞实验.将HT-22 细胞分为对照组(未处理)、Aβ25-35 组(用 20 μmol/L Aβ25-35 处理 24小时)、淫羊藿苷组(先用 20 μmol/L淫羊藿苷预处理 60 分钟,然后用 20 μmol/L Aβ25-35 再处理 24小时)以及淫羊藿苷+LY294002组[用 20 μmol/L淫羊藿苷和 20 μmol/L LY294002,一种磷脂酰肌醇-3-激酶(PI3K)信号通路抑制剂,处理 60 分钟,然后暴露于 20 μmol/L Aβ25-35 24 小时],并测量细胞活力.使用Western blot检测突触相关蛋白[突触素(SYP)和突触后密度蛋白-95(PSD-95)]和PI3K信号通路相关蛋白[磷酸化(p)-PI3K/PI3K、p-蛋白激酶(Akt)/Akt和p-哺乳动物雷帕霉素靶蛋白(mTOR)/mTOR)]的表达水平.结果 (1)动物实验.与APP/PS1 组相比,BSTSD组显示出逃避潜伏期显著缩短(P<0.01),越过原始平台的频率显著增加(P<0.01).形态学观察显示,BSTSD治疗后海马CA1 区锥体细胞排列更规则,核染色均匀,空泡样变化减少.TEM显示,与APP/PS1组相比,BSTSD治疗组的突触活动区长度增加(P<0.01),突触间隙宽度减少(P<0.01).(2)细胞实验.淫羊藿苷在不超过 20 μmol/L的浓度下对HT-22 细胞无明显毒性(P>0.05),并且能够缓解Aβ25-35 诱导的细胞活力下降(P<0.01).Western blot结果显示,与Aβ25-35 组相比,淫羊藿苷组的p-PI3K/PI3K、p-Akt/Akt和p-mTOR/mTOR的比值显著增加(P<0.01),而 SYP和 PSD-95的蛋白表达水平也增加(P<0.01).这些效果可被 LY294002所阻断(P<0.01).结论 补肾填髓方和淫羊藿苷通过激活PI3K/Akt/mTOR通路,增强AD模型中的认知功能和突触完整性,为潜在的治疗策略提供了可能.
Modulation of synaptic damage by Bushen Tiansui Decoction via the PI3K signaling pathway in an Alzheimer's disease model
Objective To explore the therapeutic effect and mechanism of Bushen Tiansui Decoction(补肾填髓方,BSTSD)and its active component icariin on Alzheimer's disease(AD).Methods(i)Animal experiments.This study conducted experiments using specific pathogen-free(SPF)grade male C57BL/6J wild-type(WT)mice and APP/PS1 double transgenic mice.The animals were divided into three groups:WT group(WT mice,n=5,receiving distilled wa-ter daily),APP/PS1 group(APP/PS1 double transgenic mice,n=5,receiving distilled water daily),and BSTSD group[APP/PS1 double transgenic mice,n=5,treated with BSTSD suspen-sion at a dosage of 27 g/(kg·d)for 90 d].Cognitive function was assessed using the Morris wa-ter maze(MWM).Post-experiment,hippocampal tissues were collected for analysis of pyra-midal cell and synaptic morphology through hematoxylin-eosin(HE)staining and transmis-sion electron microscopy(TEM).(ii)Cell experiments.The HT-22 cells were divided into con-trol group(untreated),Aβ25-35 group(treated with 20 μmol/L Aβ25-35 for 24 h),icariin group(pre-treated with 20 μmol/L icariin for 60 min,followed by 20 μmol/L Aβ25-35 for an additional 24 h),and icariin+LY294002 group[treated with 20 μmol/L icariin and 20 μmol/L LY294002(an inhibitor of the phosphoinostitide 3-kinases(PI3K)signaling pathway)for 60 min,then exposed to 20 μmol/L Aβ25-35 for 24 h],and cell viability was measured.Western blot was used to detect the expression levels of synapse-associated proteins[synaptophysin(SYP)and post-synaptic density-95(PSD-95)]and PI3K signaling pathway associated proteins[phosphorylat-ed(p)-PI3K/PI3K,p-protein kinase B(Akt)/Akt,and p-mechanistic target of rapamycin(mTOR)/mTOR].Results(i)Animal experiments.Compared with APP/PS1 group,BSTSD group showed that escape latency was significantly shortened(P<0.01)and the frequency of crossing the origi-nal platform was significantly increased(P<0.01).Morphological observation showed that pyramidal cells in the hippocampal CA1 region were arranged more regularly,nuclear stain-ing was uniform,and vacuole-like changes were reduced after BSTSD treatment.TEM showed that the length of synaptic active zone in BSTSD treatment group was increased com-pared with APP/PS1 group(P<0.01),and the width of synaptic gap was decreased(P<0.01).(ii)Cell experiments.Icariin had no obvious toxicity to HT-22 cells when the concentration was not more than 20 μmol/L(P>0.05),and alleviated the cell viability decline induced by Aβ25-35(P<0.01).Western blot results showed that compared with Aβ25-35 group,the ratios of p-PI3K/PI3K,p-Akt/Akt and p-mTOR/mTOR in icariin group were significantly increased(P<0.01),while the protein expression levels of SYP and PSD-95 were increased(P<0.01).These effects were blocked by LY294002(P<0.01).Conclusion BSTSD and icariin enhance cognitive function and synaptic integrity in AD mod-els and provide potential therapeutic strategies through activation of the PI3K/Akt/mTOR pathway.

Alzheimer's disease(AD)SynapsesBushen Tiansui Decoction(补肾填髓方,BSTSD)IcariinPhosphoinostitide 3-kinases(PI3K)

惠珊、郑庆、李宏丽、朱乐枚、吴蓓蓓、梁力晖、杨静静

展开 >

湖南师范大学第一附属医院湖南省人民医院老年病科,湖南 长沙 410005,中国

中南大学湘雅二医院代谢疾病国家临床医学研究中心中西医结合科,湖南 长沙 410011,中国

中南大学湘雅医院老年疾病国家临床医学研究中心临床护理教研室,湖南 长沙 410008,中国

阿尔茨海默病 突触 补肾填髓方 淫羊藿苷 磷脂酰肌醇3激酶(PI3K)

2024

数字中医药(英文)
湖南中医药大学,中华中医药学会

数字中医药(英文)

ISSN:2096-479X
年,卷(期):2024.7(3)